|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 17760 |
FusionGeneSummary for ISL2_PEAK1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: ISL2_PEAK1 | Fusion gene ID: 17760 | Hgene | Tgene | Gene symbol | ISL2 | PEAK1 | Gene ID | 64843 | 79834 |
| Gene name | ISL LIM homeobox 2 | pseudopodium enriched atypical kinase 1 | |
| Synonyms | - | SGK269 | |
| Cytomap | 15q24.3 | 15q24.3 | |
| Type of gene | protein-coding | protein-coding | |
| Description | insulin gene enhancer protein ISL-2ISL2 transcription factor, LIM/homeodomain, (islet-2)islet-2 | pseudopodium-enriched atypical kinase 1NKF3 kinase family membersugen kinase 269tyrosine-protein kinase SgK269 | |
| Modification date | 20180519 | 20180523 | |
| UniProtAcc | Q96A47 | Q9H792 | |
| Ensembl transtripts involved in fusion gene | ENST00000290759, | ENST00000560626, ENST00000558305, ENST00000567337, ENST00000312493, | |
| Fusion gene scores | * DoF score | 1 X 1 X 1=1 | 6 X 5 X 4=120 |
| # samples | 1 | 7 | |
| ** MAII score | log2(1/1*10)=3.32192809488736 | log2(7/120*10)=-0.777607578663552 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: ISL2 [Title/Abstract] AND PEAK1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Tgene | PEAK1 | GO:0016477 | cell migration | 20534451 |
| Tgene | PEAK1 | GO:0034446 | substrate adhesion-dependent cell spreading | 20534451 |
| Tgene | PEAK1 | GO:0046777 | protein autophosphorylation | 20534451 |
| Tgene | PEAK1 | GO:0051893 | regulation of focal adhesion assembly | 23105102 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | LD | SKCM | TCGA-DA-A3F5-06A | ISL2 | chr15 | 76629282 | + | PEAK1 | chr15 | 77474382 | - |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-5UTR | ENST00000290759 | ENST00000560626 | ISL2 | chr15 | 76629282 | + | PEAK1 | chr15 | 77474382 | - |
| 5CDS-5UTR | ENST00000290759 | ENST00000558305 | ISL2 | chr15 | 76629282 | + | PEAK1 | chr15 | 77474382 | - |
| 5CDS-intron | ENST00000290759 | ENST00000567337 | ISL2 | chr15 | 76629282 | + | PEAK1 | chr15 | 77474382 | - |
| 5CDS-5UTR | ENST00000290759 | ENST00000312493 | ISL2 | chr15 | 76629282 | + | PEAK1 | chr15 | 77474382 | - |
Top |
FusionProtFeatures for ISL2_PEAK1 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ISL2 | PEAK1 |
| Transcriptional factor that defines subclasses ofmotoneurons that segregate into columns in the spinal cord andselect distinct axon pathways. {ECO:0000250}. | Probable catalytically inactive kinase. Scaffoldingprotein that regulates the cytoskeleton to control cell spreadingand migration by modulating focal adhesion dynamics(PubMed:23105102, PubMed:20534451). Acts as a scaffold formediating EGFR signaling (PubMed:23846654).{ECO:0000269|PubMed:20534451, ECO:0000269|PubMed:23105102,ECO:0000269|PubMed:23846654}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for ISL2_PEAK1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ISL2_PEAK1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| ISL2 | LHX3, ISL1, COPS5, IDI2, SSBP2, SSBP4, LHX4, SSBP3, LMO2, ARIH1 | PEAK1 | CRK, GRB2, PPP1CC, PPP1CA, NCK2, CARD8, SH2D2A, AURKA, PPP1R3A, CRKL, SORT1, XRCC5, TOR1AIP1, CDH1, PTPRK, SHC1, VWA5A, BBS7, DQX1, PCDHB11, AARSD1, MTNR1B |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ISL2_PEAK1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for ISL2_PEAK1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|